Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pharmacogenomics Approach in Psychiatry Disorders



Sarhangi N1 ; Sharifi F2, 3 ; Nikfar S1 ; Hasanzad M1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Source: Koomesh Published:2022

Abstract

Psychiatric disorders are important health issues in the world, and their management is facing some serious challenges. Drugs that are widely used in the treatment of psychiatric disorders, including antidepressants, antipsychotics, and mood stabilizers, are often associated with many side effects and are adequately effective only in a small proportion of patients. Many factors, including genetic factors, affect the effectiveness of medications prescribed for mental health disorders. Pharmacogenetics is the study of the association between genetic variations in genes encoding carriers, receptors, and drug-metabolizing enzymes with drug response. Many genes have been identified as affecting the drugs responsible for psychiatric disorders and genetic variation can lead to variations in the efficacy and side effects of drugs. This review article summarizes some psychiatric drugs and related genes, which could have potential functional effects. © 2022, Semnan University of Medical Sciences. All rights reserved.
Related Docs
1. Complex Role of the Serotonin Receptors in Depression: Implications for Treatment, Understanding Depression (2018)
2. Serotonin Transporter Functional Polymorphisms Potentially Increase Risk of Schizophrenia Separately and As a Haplotype, Scientific Reports (2022)
3. Brain, Blood, Cerebrospinal Fluid, and Serum Biomarkers in Schizophrenia, Psychiatry Research (2018)
4. Adult Rat Morphine Exposure Changes Morphine Preference, Anxiety, and the Brain Expression of Dopamine Receptors in Male Offspring, International Journal of Developmental Neuroscience (2018)
Experts (# of related papers)
Nasim Vousooghi (1)